Daniel Gil, PhD
Chief Executive Officer
30+ years in Pharma/Biotech. As Allergan VP, oversaw pre-clinical to early phase 2 clinical development and contributed to development of 4 marketed drugs and 13 clinical candidates.
LOADING
30+ years in Pharma/Biotech. As Allergan VP, oversaw pre-clinical to early phase 2 clinical development and contributed to development of 4 marketed drugs and 13 clinical candidates.